The Act will establish third party rights to challenge the validity of a patent through postgrant opposition proceedings.
William Gaede
Advertisement
Articles by William Gaede
Advertisement
Latest Updated Articles
IP Briefs: Demystifying the Patent Reform Act and its Impact on Company IP StrategyPublished: January 1st 2007 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
